Vyas et al. revealed that the combined inhibition of PI3K and mTOR using dactolisib significantly attenuated neuroinflammatory responses and seizure severity in an inflammatory model of epilepsy, highlighting the limitations of selective mTORC1 inhibition and the advantage of dual blockade in overcoming feedback reactivation mechanisms [29]. The gene discussed is MTOR; the disease is epilepsy.